Blisovi fe

Blisovi Fe is a combined oral contraceptive pill containing norethindrone and ethinyl estradiol with ferrous fumarate, approved by the FDA for pregnancy prevention. Most US insurance plans, including Medicaid and ACA-compliant policies, cover Blisovi Fe as a preventive medication under women’s health benefits.

Patients pay an average copay of $0–$30 per month for Blisovi Fe with commercial insurance, based on GoodRx data from 2023. Insurance formularies list both Blisovi Fe 1/20 and Blisovi Fe 1.5/30 as covered options; examples include Aetna and Blue Cross Blue Shield plans, YourInsurance.info states.

Prior authorization requirements for Blisovi Fe are rare but may occur in some employer-sponsored or high-deductible plans according to Cigna’s 2024 formulary documentation. Generic versions of Blisovi Fe (such as Junel Fe) are available and typically have lower out-of-pocket costs than brand-name formulations per CVS Caremark pricing reports.

Insurers classify Blisovi Fe as a Tier 1 or Tier 2 drug, which usually means lowest or mid-level copays compared to non-preferred brands in UnitedHealthcare’s published tiers. Pharmacies process claims for Blisovi Fe electronically using the patient’s prescription benefit information at point of sale, confirmed by Express Scripts’ adjudication guidelines.